重视高血压患者微量白蛋白尿的筛查与诊治

微量白蛋白尿是糖尿病肾病的早期标志之一。近年许多研究表明,微量白蛋白尿与高血压密切相关,是高血压患者心血管事件的独立危险因素,进行微量白蛋白尿筛查有助于发现早期肾脏损害与心血管高危人群,从而采取早期干预措施。有效降压是治疗微量白蛋白尿的基础,而血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂在减少微量白蛋白尿方面可能具有较好效果。

Management of Microalbuminuria in Patients with Hypertension

Microalbuminuria is an indicator of renal disease in diabetes patients.Several recent studies have also suggested that hypertension is associated with microalbuminuria,which is an independent risk factor for cardiovascular events.If used as a screening tool for cardiovascular events,microalbuminuria could identify high-risk individuals,and assist in early intervention strategies.Regimens based on angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors are considered to be a suitable treatment for hypertensive or diabetic patients with microalbuminuria.